Literature DB >> 22110772

Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.

Pit Sertznig1, Jörg Reichrath.   

Abstract

Since their discovery it has become clear that peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors involved in the genetic regulation of the lipid metabolism and energy homoeostasis. Subsequently, accumulating evidence suggests a role of PPARs in genomic pathways including the regulation of cell growth, apoptosis and differentiation. These findings indicate that PPARs and PPAR agonists play an important role in inflammatory responses and tumor promotion. Because of their diverse biologic activities on keratinocytes and other skin cells, PPARs represent a major research target for the understanding and treatment of many skin pathologies, such as hyperproliferative and inflammatory diseases. Overmore recent clinical trials identified PPARs as promising drug targets for the prevention and treatment of various diseases in the field of dermatology. The present review summarizes the current knowledge of PPAR functions in various skin disorders particularly those involving inflammation and epidermal hyperproliferation (i.e., psoriasis, atopic dermatitis, acne, scleroderma, skin malignancies).

Entities:  

Keywords:  PPAR; atopic dermatitis; cancer; dermatology; inflammation; psoriasis; scleroderma

Year:  2011        PMID: 22110772      PMCID: PMC3219163          DOI: 10.4161/derm.3.3.15025

Source DB:  PubMed          Journal:  Dermatoendocrinol        ISSN: 1938-1972


  90 in total

Review 1.  Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Authors:  B Desvergne; W Wahli
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

Review 2.  The PPARs: from orphan receptors to drug discovery.

Authors:  T M Willson; P J Brown; D D Sternbach; B R Henke
Journal:  J Med Chem       Date:  2000-02-24       Impact factor: 7.446

3.  Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation.

Authors:  S Kippenberger; S M Loitsch; M Grundmann-Kollmann; S Simon; T A Dang; K Hardt-Weinelt; R Kaufmann; A Bernd
Journal:  J Invest Dermatol       Date:  2001-12       Impact factor: 8.551

4.  Zileuton, a new efficient and safe systemic anti-acne drug.

Authors:  Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2009-05

5.  Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production.

Authors:  Ch C Zouboulis; A Saborowski; A Boschnakow
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

Review 6.  International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.

Authors:  Liliane Michalik; Johan Auwerx; Joel P Berger; V Krishna Chatterjee; Christopher K Glass; Frank J Gonzalez; Paul A Grimaldi; Takashi Kadowaki; Mitchell A Lazar; Stephen O'Rahilly; Colin N A Palmer; Jorge Plutzky; Janardan K Reddy; Bruce M Spiegelman; Bart Staels; Walter Wahli
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

7.  Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin.

Authors:  K Müller-Decker; G Reinerth; P Krieg; R Zimmermann; H Heise; C Bayerl; F Marks; G Fürstenberger
Journal:  Int J Cancer       Date:  1999-08-27       Impact factor: 7.396

Review 8.  Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials.

Authors:  Thomas K Eigentler; Ulrich M Caroli; Peter Radny; Claus Garbe
Journal:  Lancet Oncol       Date:  2003-12       Impact factor: 41.316

9.  Inhibition of melanoma metastases by fenofibrate.

Authors:  Maja Grabacka; Wojciech Placha; Przemyslaw M Plonka; Stanislawa Pajak; Krystyna Urbanska; Piotr Laidler; Andrzej Slominski
Journal:  Arch Dermatol Res       Date:  2004-06-15       Impact factor: 3.017

10.  Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice.

Authors:  L Michalik; B Desvergne; N S Tan; S Basu-Modak; P Escher; J Rieusset; J M Peters; G Kaya; F J Gonzalez; J Zakany; D Metzger; P Chambon; D Duboule; W Wahli
Journal:  J Cell Biol       Date:  2001-08-20       Impact factor: 10.539

View more
  17 in total

1.  Ancient friends, revisited: New aspects on the important role of nuclear receptor signalling for skin physiology and for the treatment of skin diseases.

Authors:  Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 2.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

3.  Preclinical studies of a specific PPARγ modulator in the control of skin inflammation.

Authors:  Arianna Mastrofrancesco; Daniela Kovacs; Massimiliano Sarra; Emanuela Bastonini; Giorgia Cardinali; Nicaela Aspite; Emanuela Camera; Philippe Chavatte; Pierre Desreumaux; Giovanni Monteleone; Mauro Picardo
Journal:  J Invest Dermatol       Date:  2013-10-28       Impact factor: 8.551

4.  Multiple Transcriptome Data Analysis Reveals Biologically Relevant Atopic Dermatitis Signature Genes and Pathways.

Authors:  Debajyoti Ghosh; Lili Ding; Umasundari Sivaprasad; Esmond Geh; Jocelyn Biagini Myers; Jonathan A Bernstein; Gurjit K Khurana Hershey; Tesfaye B Mersha
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

5.  Palmitic acid induces production of proinflammatory cytokines interleukin-6, interleukin-1β, and tumor necrosis factor-α via a NF-κB-dependent mechanism in HaCaT keratinocytes.

Authors:  Bing-rong Zhou; Jia-an Zhang; Qian Zhang; Felicia Permatasari; Yang Xu; Di Wu; Zhi-qiang Yin; Dan Luo
Journal:  Mediators Inflamm       Date:  2013-08-29       Impact factor: 4.711

6.  The activation of PPARγ by 2,4,6-Octatrienoic acid protects human keratinocytes from UVR-induced damages.

Authors:  Enrica Flori; Arianna Mastrofrancesco; Daniela Kovacs; Barbara Bellei; Stefania Briganti; Vittoria Maresca; Giorgia Cardinali; Mauro Picardo
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

7.  Oleoylethanolamide inhibits α-melanocyte stimulating hormone-stimulated melanogenesis via ERK, Akt and CREB signaling pathways in B16 melanoma cells.

Authors:  Juan Zhou; Tong Ren; Ying Li; Anran Cheng; Wanyi Xie; Lanxi Xu; Lu Peng; Jinbin Lin; Lianxiang Lian; Yong Diao; Xin Jin; Lichao Yang
Journal:  Oncotarget       Date:  2017-05-23

Review 8.  Ursolic Acid-Regulated Energy Metabolism-Reliever or Propeller of Ultraviolet-Induced Oxidative Stress and DNA Damage?

Authors:  Yuan-Hao Lee; Youping Sun; Randolph D Glickman
Journal:  Proteomes       Date:  2014-08-06

Review 9.  Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis.

Authors:  Hae-Jin Lee; Seung-Hun Lee
Journal:  Allergy Asthma Immunol Res       Date:  2014-03-21       Impact factor: 5.764

10.  Identification of a novel PPARβ/δ/miR-21-3p axis in UV-induced skin inflammation.

Authors:  Gwendoline Degueurce; Ilenia D'Errico; Christine Pich; Mark Ibberson; Frédéric Schütz; Alexandra Montagner; Marie Sgandurra; Lionel Mury; Paris Jafari; Akash Boda; Julien Meunier; Roger Rezzonico; Nicolò Costantino Brembilla; Daniel Hohl; Antonios Kolios; Günther Hofbauer; Ioannis Xenarios; Liliane Michalik
Journal:  EMBO Mol Med       Date:  2016-08-01       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.